Weekly Digests
‹ Back to August

Specificity of inhibitory KIRs enables NK cells to detect changes in an altered peptide environment

August 2, 2017

The simple hypothesis that NK cells discriminate “self” from “non-self” based on surface HLA expression understates the complexity of NK cell recognition, and now needs to be extended to include discrimination of “altered self”. As the recent study by Carrillo-Bustamante et al. suggests, changes in the peptide-ligand repertoire appear to play a role in NK cell regulation as well.

NK cell recognition of target cells is tightly controlled by the interactions between the inhibitory and activating killer-cell immunoglobulin-like receptors (KIRs) and their corresponding ligands - the most common ones being HLA-A3/11, HLA-B Bw4, HLA-C C1, and HLA-C C2. Malmberg et al. describe that the KIR gene family has up to 17 members, which vary in number between individuals and exhibit allele-specific polymorphisms. As explained in a review of KIR evolution by Hilton and Parham, the extensive genetic diversity and polymorphism of both the KIR and HLA class I genes result in a diverse NK cell response among individuals, differentially impacting sensitivity to infection, autoimmunity, and reproduction.

In addition to the allele-generated diversity, there is now increasing evidence that NK cells utilize HLA-bound peptide selectivity (possibly at positions P7 and P8) as another level of control for inhibition or activation. In an attempt to quantify the specificity required at the ligand-peptide level for NK activation and how this relates to inhibitory KIR (iKIR) genetic diversity, Carrillo-Bustamante et al. evaluated the changes in the repertoire of the peptide-HLA class I complexes that occur during measles viral infections in a set of B-cell lymphoblastoid cell lines (BLCLs).

The researchers found that the number of unique peptides decreased in all four BLCLs after infection with a measles virus, although the total number of peptides increased in two of the cell lines. Surprisingly, the density of most ligand sequence motifs at P7 and P8 decreased in all cell lines. As a decreasing ligand density leads to enhanced NK cell activation, the observed large decrease in ligand concentration is likely to trigger a strong NK cell response. Interestingly, the majority of peptides detected after viral infection were derived from self-proteins, while only a few were of viral origin, implying that changes in self-peptide presentation may be sufficient to detect a viral infection.

The analysis performed by Carrillo-Bustamante et al. implies that iKIRs could only detect the changes in the peptide-HLA class I repertoire if the iKIRs were sufficiently specific (i.e., able to distinguish between different amino acids in the contact residues of the peptide), and the simulation model utilized by the researchers led to the conclusion that one single iKIR per individual host would be insufficient to detect repertoire changes, which may explain the evolution of the KIR multigene family. The validity of these conclusions depends crucially on the actual specificity of iKIRs, which remains unknown at this point.

The results of this study, together with previous research, suggest that the current model of NK cell activation, which includes the detection of “missing self” (no HLA expression) and “induced self” (activating ligands), should be augmented to include the “altered self” scenario, in which virus-induced peptide-HLA class I repertoire changes can activate NK cells by either promoting binding to the activating KIRs or disrupting binding to the iKIRs, even in the absence of HLA class I downregulation. Alternatively, the target cell could inhibit NK cell activation by presenting peptide:HLA complexes that bind strongly to the iKIRs, allowing the virus (or a tumor) to escape detection.

Finally, as mentioned in a review by Malmberg et al., NK cells have the potential to play a role in allogeneic adoptive immunotherapy, particularly in converting patients with acquired resistance to checkpoint inhibition therapy via HLA loss into clinical responders. Terminally differentiated memory NK cells (a.k.a. adaptive NK cells) have the advantage of homogeneous expression of a single HLA-specific self-KIR, rendering these cytolytic cells completely safe for normal tissue not expressing the target HLA and making them attractive candidates for cancer treatment.

Despite the challenges that remain to fully understand the mechanism behind NK cell specificity and functionality, the work by Carrillo-Bustamante et al. brings scientists one step closer to utilizing this highly active immune cell population to enhance cancer immunotherapy.

by Anna Scherer


Carrillo-Bustamante P., de Boer R.J., Keşmir C. Specificity of inhibitory KIRs enables NK cells to detect changes in an altered peptide environment. Immunogenetics. 2017 Jul 10.

Hilton H.G., Parham P. Missing or altered self: human NK cell receptors that recognize HLA-C. Immunogenetics. 2017 Jul 10.

Malmberg K.J., Sohlberg E., Goodridge J.P., Ljunggren H.G. Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition. Immunogenetics. 2017 Jul 11.

In the Spotlight...

Myeloid suppressor cells in cancer and autoimmunity

Sica and Massarotti review how tumors hijack some of the mechanisms that the tumor associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) innate immune populations utilize in preventing autoimmunity to instead promote and sustain cancer and prevent its immune control.

Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation

Contrary to expectations, lentiviral vector (LV) initiated an immune response via “pseudotransduction” - the direct delivery of antigen packaged in the virus - rather than by the intended expression of antigen-encoding DNA. LVs induced dendritic cell activation via two pathways: viral-mediated membrane fusion induced a P13K-dependent pathway, while pseudotransduced human genomic DNA activated a STING- and cGAS-dependent pathway.

The immune contexture in cancer prognosis and treatment

This review by Fridman et al. describes how the density, functional state, and organization of immune cell infiltrates in the tumor (the immune contexture) relate to prognosis. They explore how contexture and prognosis vary with disease subtype and evolve with progression and treatment (chemotherapy, radiotherapy, and immunotherapy). Relevant current and emerging technologies are highlighted.

Therapeutic vaccine to cure large mouse hepatocellular carcinomas

Han et al. demonstrated that intra-tumoral vaccines containing the TLR4 stimulant HMGN1, the TLR7/8 stimulant R848, and either a checkpoint inhibitor (anti-PD-L1 or anti-CTLA-4) or cytoxan (to reduce Treg function) completely cured large Hepa1-6 tumors, protected mice from rechallenge, and had a moderate effect on tumors at distant sites in a murine hepatocellular carcinoma model.

Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer

In triple negative breast cancer samples from TCGA, good clinical outcomes correlate positively with stronger T cell infiltration but negatively with measures of tumor heterogeneity, mutation burden, and neoantigen load, implying that effective immune surveillance may get eliminated over time as the mutation landscape evolves to select multiple, less immunogenic escape variants.

Regulation of inflammation by microbiota interactions with the host

Blander et al. specifically review the role of the multi-kingdom gut microbiome in innate and adaptive immunity, including direct effects on immune and nonimmune cells, disease development and progression due to chronic inflammation, modulation of inflammation at distal sites (including the hygiene hypothesis), and effects on host immune response to vaccines and cancer therapies.

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent anti-tumor activity

To overcome the intrinsic difficulty of patient-specific manufacturing of CAR-T cells, Liu et al. demonstrate in a murine xenograft model that cord-blood derived allogeneic NK cells transduced with a construct expressing a CD19-CAR, IL-15 (to promote NK cell proliferation and in vivo persistence), and a suicide gene effectively control a B-cell lymphoma without evidence of long term leukemogenesis, supporting initiation of a clinical trial.

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells

Using the T-cell-inflamed mouse oral cancer 1 (MOC1) model, Clavijo et al. found that depletion of granulocytic myeloid-derived suppressor cells (gMDSCs) rescued the lytic function of intra-tumoral effector T lymphocytes and NK cells and sensitized MOC1 tumors to CTLA-4 checkpoint blockade, leading to complete rejection and immunologic memory. The CXCR2 chemokine was linked to recruiting gMDSCs to the tumor.

Everything New this Week In...